13 results
F-3
CALT
Calliditas Therapeutics AB
28 Jun 22
Shelf registration (foreign)
4:49pm
such negative outcome could result in payments of substantial damages or fines, damage to our reputation or adverse changes to our business practices
6-K
EX-10.1
CALT
Calliditas Therapeutics AB
23 Jul 21
Calliditas Therapeutics and STADA partner to register and commercialize specialty therapy for IgA Nephropathy in Europe
4:03pm
Trademarks or the reputation or goodwill associated with the Calliditas Trademarks, or that may invalidate or jeopardize any registration of Calliditas … consecutive Calendar Quarters (as reasonably determined by Partner on the basis of unit sales data from IQVIA or another source of comparable reputation
20-F
km19ba6u1tz
27 Apr 21
Annual report (foreign)
5:16pm
F-1
ct8tlmo5jv 4ew
26 Jan 21
Registration statement (foreign)
4:33pm
DRS
gw9s5a62iu y6dj5b1xk
29 Dec 20
Draft registration statement
12:00am
424B4
pplxyjq4ox6h oni2
8 Jun 20
Prospectus supplement with pricing info
9:18am
F-1/A
fcren8 up9vn
1 Jun 20
Registration statement (foreign) (amended)
7:01am
F-1
lmxwoax stv9yz
14 May 20
Registration statement (foreign)
8:56am
DRS/A
bkx4worsg5e
2 Mar 20
Draft registration statement (amended)
12:00am
DRS
fwbsfs0j
13 Dec 19
Draft registration statement
12:00am
- Prev
- 1
- Next